History’s deadliest infectious disease has a new adversary. Although many think of tuberculosis as a disease of the past, it still kills 1.2 million people annually. Last month, scientists at Texas A&M AgriLife Research published a study in Nature, revealing that they had developed a new compound that could be a tuberculosis treatment breakthrough. The… The post Scientists have discovered a potential new treatment for tuberculosis – even drug-resistant strains appeared first on Drug D...| Drug Discovery and Development
New UBC study reveals benztropine’s potential to treat the world’s deadliest infectious disease and combat growing antibiotic resistance.| UBC News
A team of researchers from Case Western Reserve University School of Medicine’s Department of Pharmacology recently conducted a study to better understand how essential transport proteins function in Mycobacterium smegmatis, a model organism used to study tuberculosis-related bacteria. Their findings are expected to be published next month in Science Advances in an article titled “Structures of MmpL complexes reveal the assembly and mechanism of this family of transporters.” Researc...| The Daily
Meanwhile, the WHO is mulling “terrible choices” as it tries to trim 25% of its budget in the wake of the US withdrawal from the body.| Health Policy Watch
Where is the “infection?” One of the reasons I like to engage with people who challenge me about pathogenic “viruses” and bacteria is that I always come away with something new from the…| ViroLIEgy
2min read Apparently we need to mass vaccinate for "latent" diseases| PANDA
On World TB Day 2025, we look at the most recent data, which showed a rise of 13% in reported numbers of cases in England between 2023 and 2024.| ukhsa.blog.gov.uk
Tuberculosis (TB) is a big killer in many countries of the world, particularly in those with low and middle income. Next-generation sequencing has been key in improving our understanding of drug resistance acquisition and of transmission of Mycobacterium tuberculosis. Yet, the need for expertise guiding NGS implementation in laboratories and the lack of bioinformatic expertise, are main obstacles hindering the implementation of NGS into TB programs.| Galaxy Training Network